Terns Pharmaceuticals, Inc. (TERN) Tops Q2 EPS by 3c

Terns Pharmaceuticals, Inc. (NASDAQ: TERN) reported Q2 EPS of ($0.31), $0.03 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Terns Pharmaceuticals, Inc. (TERN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Ticketplus files for IPO with shares priced between $13-$15
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters